Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients
REGULATED INFORMATION
INSIDE INFORMATION
Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients
Reports an Apnea-Hypopnea Index (AHI) responder rate of 77.2% on a Full Analysis …